Uribe M, Moreno Berthier J, Guevara L, Ramírez-Acosta J, Márquez M A, Arce A
Rev Gastroenterol Mex. 1979 Apr-Jun;44(2):63-6.
Two cirrhotic patients with hepatorenal syndrome were treated with Dopamine hydrochloride and Bromocriptine, a Dopamine agonist. Dopamine hydrochloride was given at a dosis of 0.30 to 0.90 mg/min. and Bromocriptine 15 mg/day. Although a transient raise of urinary output was observed in one patient, both patients died six to ten days later with an urinary output of less than 100 ml/day. Dopamine and Bromocriptine combined are of poor therapeutic value in hepatorenal syndrome.
两名患有肝肾综合征的肝硬化患者接受了盐酸多巴胺和多巴胺激动剂溴隐亭的治疗。盐酸多巴胺的给药剂量为0.30至0.90毫克/分钟，溴隐亭为15毫克/天。尽管其中一名患者出现了尿量短暂增加的情况，但两名患者均在六至十天后死亡，尿量不足100毫升/天。多巴胺和溴隐亭联合使用对肝肾综合征的治疗价值不大。
